Participants
Why It Matters
The infusion of $55 million accelerates commercialization of sustainable, animal‑free egg proteins, offering food producers a low‑environmental‑impact alternative and reshaping supply chains in the protein market.
Deal Summary
The EVERY Company, a precision‑fermentation biotech firm, announced a $55 million Series D round to expand its egg‑protein ingredient platform. The financing was led by McWin Capital Partners with participation from Main Sequence, Bloom8, TO.VC, Minerva Foods, Grosvenor Food & Ag, New Agrarian, SOSV and others.
Comments
Want to join the conversation?
Loading comments...